ICH GCP E6 R2 and R3 Updates: Overview of Changes Impacting Sponsors, CROs, Clinical Investigators/Sites

Oct 6, 2018, 18:22 PM
Course ID : 210
Acronym : CTCICH
Stay ahead with Barnett International's insights into ICH GCP R2 & R3. Empower your clinical journey today.

Course Description

For the first time in over 20 years, the International Council for Harmonization (ICH) Good Clinical Practice (GCP) E6 R2 Guideline was significantly updated. The revisions were intended to encourage implementation of improved and more efficient approaches to clinical trial design, conduct, oversight, recording and reporting while continuing to ensure human subject protection and reliability of trial results, and have had resounding effects on the conduct of clinical research by sponsors/CROs and investigators. This web seminar provides a targeted overview of the changes, including implications of the upcoming R3 updates, with summary explanations of the changes, per the Guideline. Topics include: ICH principles, ICH definitions, sponsor/CRO responsibilities, investigator responsibilities, and essential documents. Understanding these changes and how they impact your organization is the first critical step towards organizational analysis implementation.

Learning Objectives

  • Explain the rationale for the ICH GCP addendums (E6 R2 and R3)
  • Describe the E6 R2 terms that are new/updated
  • Identify the individual changes that comprise E6 R2 and proposed changes for R3
  • Recognize the importance and impact of the changes for the sponsor/CRO and investigators/sites responsibilities

Who Should Attend

  • Managers/Directors: Clinical Operations, Clinical Research, Quality Management, Compliance
  • Study Managers, Project Managers
  • Clinical Research Associates/Monitors
  • Quality Assurance Personnel

Instructor

Nikki Christison, B.S., C.C.R.A., T.I.A.C.R.

Click here for complete trainer biographies

Registration Fees

$835

Includes up to 20 participants at one site. All participants (up to 20) are eligible for “Certificates of Attendance,” and accreditation, provided that accreditation requirements are met. For groups larger than 20 or for additional sites, please call +1 781.972.5400 or toll-free in the U.S. 800.856.2556 for pricing.

Note: Due to COVID-19, we understand that most teams cannot currently dial-in together. As such, we are able to offer additional logins at a highly reduced rate. Please contact Barnett Customer Service at +1 781.972.5400 or toll-free in the U.S. 800.856.2556 to register with your additional participants requiring login credentials. Or email Customer Service at: customer.service@barnettinternational.com 

Accreditation Information

Barnett International is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Participants will receive 2.5 hours (0.25 CEUs) of continuing education credit for full participation, including the completion of a pre-test, post-test, and program evaluation.  Barnett International will issue a receipt of completion for earned CEUs within three weeks of program completion.  ACPE#: 0778-0000-22-024-L04-P. Released: 7/22. 

Hold this course at your company! For more information, contact Naila Ganatra at +1 215.413.2471. 

Series :
  • Clinical Trials & Translational Medicine
Topics :
  • Clinical Research
  • Medical Device
  • Regulatory Compliance
Job Functions :
  • Clinical Operations & Trial Management
  • Clinical Quality Assurance
  • Clinical Research Associate
  • Project Manager
  • Regulatory Affairs
  • Study Site Compliance
  • Training
Related web seminar instances